Lensar (LNSR) Operating Margin (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,737.00 |
| Dec 31, 2025 | 2,873.00 |
| Sep 30, 2025 | -825.00 |
| Jun 30, 2025 | -1,028.00 |
| Mar 31, 2025 | -3,219.00 |
| Dec 31, 2024 | 49.00 |
| Sep 30, 2024 | 4,022.00 |
| Jun 30, 2024 | 93,334.00 |
| Mar 31, 2024 | -95,456.00 |
| Dec 31, 2023 | -737.00 |
| Sep 30, 2023 | 304.00 |
| Jun 30, 2023 | 2,898.00 |
| Mar 31, 2023 | -2,731.00 |
| Dec 31, 2022 | 3,952.00 |
| Sep 30, 2022 | 3,758.00 |
| Jun 30, 2022 | -1,848.00 |
| Mar 31, 2022 | -5,765.00 |
| Dec 31, 2021 | 4,802.00 |
| Sep 30, 2021 | -1,002.00 |
| Jun 30, 2021 | 2,315.00 |
| Mar 31, 2021 | -2,427.00 |
| Dec 31, 2020 | 256.00 |
| Sep 30, 2020 | 1,020.00 |
| Jun 30, 2020 | -2,367.00 |
| Mar 31, 2020 | -3,587.00 |
| Dec 31, 2019 | 4,955.00 |